 BEIJING--BUSINESS WIRE--Sinovac Biotech Ltd. NASDAQ:SVA Sinovac or the Company, a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration NMPA has granted a conditional marketing authorization CMA to Sinovac for CoronaVac, Sinovacs COVID-19 vaccine in individuals aged 18 and above. Sinovac began rolling submission to the NMPA since September 2020 and the NMPA carried out rolling reviews when the submission w 